SEC Form 4 · accession 0001209191-18-032634
SURMODICS INC · SRDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jose H Bedoya
Director
Period of report
May 21, 2018
Accepted (ET)
May 23, 2018 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000924717
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 21, 2018 | M | 11,450 | $12.40 | A | 30,889 | D | |
| Common StockF1,F2 | May 21, 2018 | S | 11,450 | $48.1737 | D | 19,439 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $12.40 | May 21, 2018 | M | 11,450 | D | — | Nov 30, 2018 | Common Stock | 11,450 | 0 | D |
Explanation of responses
- F1Reflects the weighted average price of 11,450 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on May 21, 2018 with sale prices ranging from $47.80 to $48.50 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2The amount beneficially owned includes 8,684 restricted stock units (RSUs) that vest on service-based vesting dates and 8,430 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
- F3Fully vested.